C1QTNF9 and cancer: To the best of our knowledge, this represents the first description that CTRP9 enhances the function of T cells and CAR-T cells in mammals, indicating CTRP9 may serve as a promising adjuvant to optimize the CAR-T cell-mediated cancer therapy.